Targeted therapy medications are a type of cancer treatment that works by targeting specific molecules or pathways that are involved in the growth and spread of cancer cells. Here are some examples of targeted therapy medications that may be used for the treatment of gallbladder cancer:

• Trastuzumab (Herceptin):
  Trastuzumab is a targeted therapy medication that is used to treat gallbladder cancer that has high levels of a protein called human epidermal growth factor receptor 2 (HER2). It works by binding to the HER2 protein, which slows or stops the growth of cancer cells.
• Ramucirumab (Cyramza):
  Ramucirumab is a targeted therapy medication that is used to treat advanced gallbladder cancer that has spread to other parts of the body. It works by blocking the growth of new blood vessels that supply oxygen and nutrients to the cancer cells.
• Pembrolizumab (Keytruda):
  Pembrolizumab is a targeted therapy medication that is used to treat gallbladder cancer that has a specific genetic mutation called microsatellite instability-high (MSI-H) or mismatch repair deficiency (dMMR). It works by blocking a protein called PD-1, which helps the immune system recognize and attack cancer cells.

The specific targeted therapy medications used for the treatment of gallbladder cancer will depend on a number of factors, including the stage and location of the cancer, the patient’s overall health, and other individual factors. A healthcare provider will determine the most appropriate treatment plan for each patient.

Immunotherapy is a type of cancer treatment that works by stimulating the patient’s own immune system to attack and destroy cancer cells. Here are some examples of immunotherapy medications that may be used for the treatment of gallbladder cancer:

• Pembrolizumab (Keytruda):
  Pembrolizumab is a type of immunotherapy medication known as a checkpoint inhibitor. It works by blocking a protein called PD-1, which is used by cancer cells to hide from the immune system. By blocking this protein, pembrolizumab allows the immune system to recognize and attack cancer cells.
• Nivolumab (Opdivo):
  Nivolumab is another checkpoint inhibitor that is used to treat advanced gallbladder cancer. Like pembrolizumab, it blocks the PD-1 protein to help the immune system attack cancer cells.
• Atezolizumab (Tecentriq):
  Atezolizumab is a different type of immunotherapy medication that targets a protein called PD-L1. This protein is often overexpressed on the surface of cancer cells, allowing them to evade the immune system. By blocking PD-L1, atezolizumab helps the immune system recognize and attack cancer cells.

Immunotherapy medications may be used alone or in combination with other treatments, such as chemotherapy or targeted therapy. The specific immunotherapy medications used for the treatment of gallbladder cancer will depend on a number of factors, including the stage and location of the cancer, the patient’s overall health, and other individual factors. A healthcare provider will determine the most appropriate treatment plan for each patient.

Radiation therapy uses high-energy radiation to kill cancer cells. It may be used before or after surgery, or in combination with chemotherapy. Radiation therapy can help to shrink tumors and relieve symptoms of gallbladder cancer.